Integrated Filing — IndAS
General information about company
| Scrip Code |
539787 |
| NSE Symbol |
HCG |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE075I01017 |
| Name of company |
Healthcare Global Enterprises Limited |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2026 |
| Date of end of financial year |
31-03-2027 |
| Date of board meeting when results were approved |
06-08-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
27-07-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
First quarter |
| Nature of report standalone or consolidated |
Standalone |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
|
| Segment Reporting |
Single segment |
| Description of single segment |
Healthcare |
| Start date and time of board meeting |
06-08-2026 11:30:00 |
| End date and time of board meeting |
06-08-2026 18:50:00 |
| Whether cash flow statement is applicable on company |
|
| Type of cash flow statement |
|
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Whether statement on deviation or variation for proceeds of public issue, rights issue,
preferential issue, qualified institutions placement etc. is applicable to the company for the
current quarter? |
Yes |
| No. of times funds raised during the quarter |
1 |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the
entity? |
No |
| The compnay has not defaulted in repayment of loans. The Company has not issued debt securities. |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2026 |
01-04-2026 |
| B |
Date of end of reporting period |
30-06-2026 |
30-06-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Standalone |
Standalone |
| 1 |
Income |
|
Revenue from operations |
37,666.00 |
37,666.00 |
|
Other income |
956.00 |
956.00 |
|
Total income |
38,622.00 |
38,622.00 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
0.00 |
0.00 |
| (b) |
Purchases of stock-in-trade |
9,561.00 |
9,561.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
(360.00) |
(360.00) |
| (d) |
Employee benefit expense |
5,967.00 |
5,967.00 |
| (e) |
Finance costs |
2,173.00 |
2,173.00 |
| (f) |
Depreciation, depletion and amortisation expense
|
3,957.00 |
3,957.00 |
| (f) |
Other Expenses |
| 1 |
Medical consultancy charges |
7,734.00 |
7,734.00 |
| 2 |
Other expenses |
8,842.00 |
8,842.00 |
|
Total other expenses |
16,576.00 |
16,576.00 |
|
Total expenses |
37,874.00 |
37,874.00 |
| 3 |
Total profit before exceptional items and tax |
748.00 |
748.00 |
| 4 |
Exceptional items |
0.00 |
0.00 |
| 5 |
Total profit before tax |
748.00 |
748.00 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
362.00 |
362.00 |
| 8 |
Deferred tax |
(172.00) |
(172.00) |
| 9 |
Total tax expenses |
190.00 |
190.00 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
558.00 |
558.00 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
0.00 |
0.00 |
| 16 |
Total profit (loss) for period |
558.00 |
558.00 |
| 17 |
Other comprehensive income net of taxes |
0.00 |
0.00 |
| 18 |
Total Comprehensive Income for the period |
558.00 |
558.00 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
|
|
|
Total profit or loss, attributable to non-controlling interests |
|
|
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
|
|
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
|
|
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
14,930.00 |
14,930.00 |
|
Face value of equity share capital |
10 |
10 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
0.37 |
0.37 |
|
Diluted earnings (loss) per share from continuing operations |
0.37 |
0.37 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
0.37 |
0.37 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
0.37 |
0.37 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-04-2026 |
01-04-2026 |
| Date of end of reporting
period |
30-06-2026 |
30-06-2026 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Standalone |
Standalone |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
|
Total Segment Revenue |
|
|
|
Less: Inter segment revenue |
|
|
|
Revenue from operations |
|
|
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
|
Total Profit before tax |
|
|
|
i. Finance cost |
|
|
|
ii. Other Unallocable Expenditure net off Unallocable income |
|
|
|
Profit before tax |
|
|
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
|
Total Segment Asset |
|
|
|
Un-allocable Assets |
null |
null |
|
Net Segment Asset |
null |
null |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
|
Total Segment Liabilities |
|
|
|
Un-allocable Liabilities |
null |
null |
|
Net Segment Liabilities |
null |
null |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-04-2026 |
01-04-2026 |
| B |
Date of end of reporting period |
30-06-2026 |
30-06-2026 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Standalone |
Standalone |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Remeasurements of the defined benefit plans |
0.00 |
0.00 |
| 2 |
Income tax effect on above |
0.00 |
0.00 |
|
Total Amount of items that will not be reclassified to profit and loss |
0.00 |
|
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
0.00 |
0.00 |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
Effective portion of gain on hedging instruments in cash flow hedge |
0.00 |
0.00 |
| 2 |
Income tax effect on above |
0.00 |
0.00 |
|
Total Amount of items that will be reclassified to profit and loss |
0.00 |
|
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
0.00 |
0.00 |
| 5 |
Total Other comprehensive income |
0.00 |
0.00 |
Details of Impact of Audit Qualification
Amount in (Lakhs)
| Whether results are audited or unaudited |
Unaudited |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Auditor's opinion |
|
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015:
The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified
opinion for the period on Standalone results |
Yes |
| Sr No. |
Audit firm's name |
Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI |
Certificate valid upto |
| 1 |
B S R & Co. LLP |
Yes |
31-07-2028 |
Statement on Deviation or Variation for proceeds of Public Issue, Rights
Issue, Preferential Issue, Qualified Institutions Placement Etc. (1)
Amount in (Lakhs)
| Mode of Fund Raising |
Rights Issues |
| Description of mode of fund raising
(Applicable in case of others is selected) |
|
| Date of Raising Funds |
27-03-2026 |
| Amount Raised |
42,468.18 |
| Report filed for Quarter ended |
30-06-2026 |
| Monitoring Agency |
Applicable |
| Monitoring Agency Name, if applicable |
Care Ratings Limited |
| Is there a Deviation / Variation in use of funds raised |
No |
| If yes, whether the same is pursuant to change in terms of a contract or objects,
which was approved by the shareholders |
|
| If Yes, Date of shareholder Approval |
|
| Explanation for the Deviation / Variation |
NIL |
| Comments of the Audit Committee after review |
NIL |
| Comments of the auditors, if any |
NIL |
| Sr. |
Original Object |
Modified Object, if any |
Original Allocation |
Modified allocation, if any |
Funds Utilised |
Amount of Deviation/Variation for the quarter according to applicable
object |
Remarks if any |
| 1 |
Pre-payment and/ or repayment of all, or a portion of, certain outstanding borrowings availed by our Company and by one of our wholly owned Subsidiaries, HCG NCHRI Oncology LLP |
NA |
17,000.00 |
0.00 |
17,000.00 |
0.00 |
|
| 2 |
Part-payment of consideration for acquisition of 34.00% additional stake in equity share capital of Vizag Hospital and Cancer Research Center Private Limited, one of our existing Subsidiaries |
NA |
15,403.96 |
0.00 |
15,403.96 |
0.00 |
|
| 3 |
General corporate purposes*# |
NA |
9,556.87 |
0.00 |
9,583.43 |
26.56 |
The actual Issue Related Expenses incurred were Rs. 4.81 crore as against the estimated allocation of Rs. 5.07 crore. Consequently, the unutilized amount of Rs. 0.26 crore was utilized towards General Corporate Purposes, resulting in utilization of Rs. 95.83 crore (which is less than 25% of the total issue size) under General Corporate Purposes as compared to the originally allocated amount of Rs. 95.57 crore. There was no change in the overall utilization of the net proceeds from the Issue. Please note that the aforesaid utilization is in accordance with the disclosures set out in the Offer Document and is within the overall limit prescribed under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. |
| 4 |
Issue related expenses** |
NA |
507.35 |
0.00 |
480.78 |
26.56 |
The actual Issue Related Expenses incurred were Rs. 4.81 crore as against the estimated allocation of Rs. 5.07 crore. Consequently, the unutilized amount of Rs. 0.26 crore was utilized towards General Corporate Purposes, resulting in utilization of Rs. 95.83 crore (which is less than 25% of the total issue size) under General Corporate Purposes as compared to the originally allocated amount of Rs. 95.57 crore. There was no change in the overall utilization of the net proceeds from the Issue. Please note that the aforesaid utilization is in accordance with the disclosures set out in the Offer Document and is within the overall limit prescribed under the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018. |
Signatory Details
| Name of signatory |
Sunu Manuel |
| Designation of person |
Company Secretary |
| Place |
Bangalore |
| Date |
06-08-2026 |